Pharmacokinetic study of K-877 in patients with Primary biliary cholangitis
Phase 1
Completed
- Conditions
- Primary biliary cholangitis
- Registration Number
- JPRN-jRCT2080223672
- Lead Sponsor
- Kowa Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- completed
- Sex
- All
- Target Recruitment
- 8
Inclusion Criteria
Patients with Primary biliary cholangitis
Exclusion Criteria
Person who has liver cirrhosis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method pharmacokinetics<br>Plasma concentrations and pharmacokinetics parameters of K-877<br>Central laboratory test
- Secondary Outcome Measures
Name Time Method pharmacokinetics<br>Plasma concentrations and pharmacokinetics parameters of K-877 metabolites<br>Central laboratory test